Advertisement
Screener

Tilray Brands, Inc. (TLRY) Convertible Debt, Noncurrent

2.8 / 5 stars · 68/120 Roast Me

Tilray Brands, Inc. Convertible Debt, Noncurrent

Tilray Brands, Inc. (TLRY) had Convertible Debt, Noncurrent of $79.53 million as of 2026-05-31, per its 10-K filed 2026-07-28.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities

us-gaap:ConvertibleDebtNoncurrent · last filed 2026-07-28

  • 2026-05-31: Convertible Debt, Noncurrent $79.53M.
  • 2026-02-28: Convertible Debt, Noncurrent $88.27M.
  • 2025-12-31: Convertible Debt, Noncurrent $86.43M.
  • 2025-11-30: Convertible Debt, Noncurrent $86.25M.
Period endConvertible Debt, Noncurrent
2026-05-31$79.53M
10-K · filed 2026-07-28
2026-02-28$88.27M
10-Q · filed 2026-04-01
2025-12-31$86.43M
10-K · filed 2026-07-28
2025-11-30$86.25M
10-Q · filed 2026-01-08
2025-08-31$84.27M
10-Q · filed 2025-10-09
2025-05-31$86.43M
10-K · filed 2026-07-28
2025-02-28$104.07M
10-Q · filed 2025-04-08
2024-12-31$104.07M
10-Q · filed 2025-04-08
2024-11-30$122.73M
10-Q · filed 2025-01-10
2024-08-31$132.65M
10-Q · filed 2024-10-10
2024-05-31$129.58M
10-K · filed 2025-07-29
2024-02-29$126.59M
10-Q · filed 2024-04-09
2023-12-31$129.58M
10-Q · filed 2025-04-08
2023-11-30$123.69M
10-Q · filed 2024-01-09
2023-08-31$120.86M
10-Q · filed 2024-10-10
2023-05-31$221.04M
10-Q · filed 2024-10-10
2023-02-28$223.09M
10-Q · filed 2023-04-10
2022-11-30$223.29M
10-Q · filed 2023-01-09
2022-05-31$401.95M
10-K · filed 2023-07-26
2022-03-31$401.95M
10-Q · filed 2023-01-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87